Drupal.behaviors.print = function(context) {window.print();window.close();}>
Genoptix Offers Targeted Sequencing on Ion PGM to Guide Treatment Decisions for Metastatic Melanoma
March 28, 2012
Genoptix Offers Targeted Sequencing on Ion PGM to Guide Treatment Decisions for Metastatic Melanoma
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Genoptix Says NGS Melanoma Test Will Not Be Used to Place Patients in Trials for Parent Novartis
March 28, 2012 / Pharmacogenomics Reporter
Using PacBio RS, UCSF Team Shows FLT3-ITD Mutations Are a Valid Therapeutic Target in AML
April 18, 2012 / Clinical Sequencing News
Cynvenio Offering NGS Analysis of Isolated Circulating Tumor Cells Using AmpliSeq Panel
April 10, 2013 / Clinical Sequencing News
With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test
January 2, 2013 / Clinical Sequencing News
With $15.5M Grant, EU Consortium to Sequence 1,100 Exomes to Develop Diagnostics for Neurologic Diseases
November 28, 2012 / Clinical Sequencing News